Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Management of Prolonged Menstrual Bleeding: Treatment Selection and Sequencing

First-Line Treatment Recommendations

  • Combined oral contraceptives (COCs) with 30-35 μg ethinyl estradiol are the recommended first-line treatment for managing prolonged menstrual bleeding, as they decrease menstrual blood loss by inducing regular shedding of a thinner endometrium 3, 4

  • COCs provide additional benefits including improvement in dysmenorrhea, protection against iron-deficiency anemia, and reduced risk of endometrial and ovarian cancers 1, 2

  • If COCs are contraindicated (e.g., cardiovascular risk factors, history of VTE), the levonorgestrel-releasing IUD can be considered as an alternative first-line option 2, 4

DMPA as Second-Line Treatment

  • Depo-Provera (DMPA) is NOT recommended as a first-line treatment for patients with prolonged menstrual bleeding, as it commonly causes menstrual irregularities initially and should be reserved as a second-line option after combined oral contraceptives have been tried 1, 2, 3

  • The major disadvantage of DMPA is that menstrual cycle irregularities are present for nearly all patients initially 1, 2

  • DMPA commonly causes irregular bleeding, prolonged bleeding, or heavy bleeding when first initiated 5

  • While irregular bleeding associated with DMPA typically improves over time, with 55% achieving amenorrhea by 12 months and 68% by 24 months, the initial period involves unpredictable bleeding patterns 2, 5

  • DMPA can be considered as a second-line treatment option if first-line COCs are not effective or contraindicated 3, 6

Management of Bleeding with DMPA Use

  • For breakthrough bleeding that occurs with DMPA use, NSAIDs for 5-7 days may be effective 6

  • For heavy or prolonged bleeding with DMPA, treatment options include NSAIDs for 5-7 days or hormonal treatment with low-dose COCs or estrogen for 10-20 days (if medically eligible) 4, 5

  • If DMPA is used and bleeding persists, organic pathology (STDs, pregnancy, uterine pathology like polyps or fibroids) should be ruled out before treating symptomatically 5

Patient Counseling

  • Before initiating DMPA, patients must receive thorough counseling about the high likelihood of menstrual irregularities, as patients counseled about adverse effects before their first injection are more likely to continue use 1, 2

REFERENCES

1

Management of Heavy Menstrual Bleeding in Adolescents [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Treatment of Heavy Menstrual Bleeding in PCOS Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Management of Refractory Dysmenorrhea [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025